611 related articles for article (PubMed ID: 28062125)
1. Propensity of pneumococcal carriage serotypes to infect the lower airways of children with chronic endobronchial infections.
Hare KM; Smith-Vaughan HC; Chang AB; Pizzutto S; Petsky HL; McCallum GB; Leach AJ
Vaccine; 2017 Feb; 35(5):747-756. PubMed ID: 28062125
[TBL] [Abstract][Full Text] [Related]
2. Decline in Pneumococcal Nasopharyngeal Carriage of Vaccine Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Children in Atlanta, Georgia.
Desai AP; Sharma D; Crispell EK; Baughman W; Thomas S; Tunali A; Sherwood L; Zmitrovich A; Jerris R; Satola SW; Beall B; Moore MR; Jain S; Farley MM
Pediatr Infect Dis J; 2015 Nov; 34(11):1168-74. PubMed ID: 26226445
[TBL] [Abstract][Full Text] [Related]
3. The rise and fall of pneumococcal serotypes carried in the PCV era.
Devine VT; Cleary DW; Jefferies JM; Anderson R; Morris DE; Tuck AC; Gladstone RA; O'Doherty G; Kuruparan P; Bentley SD; Faust SN; Clarke SC
Vaccine; 2017 Mar; 35(9):1293-1298. PubMed ID: 28161425
[TBL] [Abstract][Full Text] [Related]
4. Reduced nontypeable Haemophilus influenzae lower airway infection in children with chronic endobronchial suppuration vaccinated with the 10-valent pneumococcal H. influenzae protein D conjugate vaccine.
Hare KM; Smith-Vaughan HC; Leach AJ; Pizzutto SJ; McCallum GB; Chang AB
Vaccine; 2018 Mar; 36(13):1736-1742. PubMed ID: 29478754
[TBL] [Abstract][Full Text] [Related]
5. Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine.
Sharma D; Baughman W; Holst A; Thomas S; Jackson D; da Gloria Carvalho M; Beall B; Satola S; Jerris R; Jain S; Farley MM; Nuorti JP
Pediatr Infect Dis J; 2013 Feb; 32(2):e45-53. PubMed ID: 23080290
[TBL] [Abstract][Full Text] [Related]
6. Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial.
Dagan R; Patterson S; Juergens C; Greenberg D; Givon-Lavi N; Porat N; Gurtman A; Gruber WC; Scott DA
Clin Infect Dis; 2013 Oct; 57(7):952-62. PubMed ID: 23804191
[TBL] [Abstract][Full Text] [Related]
7. Dynamics of pneumococcal carriage among day-care center attendees during the transition from the 7-valent to the higher-valent pneumococcal conjugate vaccines in Greece.
Grivea IN; Priftis KN; Giotas A; Kotzia D; Tsantouli AG; Douros K; Michoula AN; Syrogiannopoulos GA
Vaccine; 2014 Nov; 32(48):6513-20. PubMed ID: 25252194
[TBL] [Abstract][Full Text] [Related]
8. Colonization with 19F and other pneumococcal conjugate vaccine serotypes in children in St. Louis, Missouri, USA.
McFarland M; Szasz TP; Zhou JY; Motley K; Sivapalan JS; Isaacson-Schmid M; Todd EM; Hogan PG; Fritz SA; Burnham CD; Hoffmann S; Morley SC
Vaccine; 2017 Aug; 35(34):4389-4395. PubMed ID: 28687405
[TBL] [Abstract][Full Text] [Related]
9. The impact of a pneumococcal conjugate vaccination program on the nasopharyngeal carriage, serotype distribution and antimicrobial resistance of Streptococcus pneumoniae among healthy children in Turkey.
Soysal A; Karabağ-Yılmaz E; Kepenekli E; Karaaslan A; Cagan E; Atıcı S; Atınkanat-Gelmez G; Boran P; Merdan S; Hasdemir U; Söyletir G; Bakır M
Vaccine; 2016 Jul; 34(33):3894-900. PubMed ID: 27269059
[TBL] [Abstract][Full Text] [Related]
10. Changes in Streptococcus pneumoniae serotype distribution in invasive disease and nasopharyngeal carriage after the heptavalent pneumococcal conjugate vaccine introduction in Bogotá, Colombia.
Parra EL; De La Hoz F; Díaz PL; Sanabria O; Realpe ME; Moreno J
Vaccine; 2013 Aug; 31(37):4033-8. PubMed ID: 23680440
[TBL] [Abstract][Full Text] [Related]
11. High invasiveness of pneumococcal serotypes included in the new generation of conjugate vaccines.
del Amo E; Brotons P; Monsonis M; Triviño M; Iñigo M; Selva L; Sa-Leão R; Muñoz-Almagro C
Clin Microbiol Infect; 2014 Jul; 20(7):684-9. PubMed ID: 24467648
[TBL] [Abstract][Full Text] [Related]
12. Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era.
Zuccotti G; Mameli C; Daprai L; Garlaschi ML; Dilillo D; Bedogni G; Faccini M; Gramegna M; Torresani E; ; Ballerini E; Benincaso A; Bonvissuto M; Bricalli D; Brioschi M; Calloni CS; Camiletti MI; Colella G; De Angelis L; Decarlis S; Di Nello F; Dozzi M; Galli E; Gandini V; Giuliani MG; Laviola F; Loda B; Macedoni M; Mazzucchi E; Metta MG; Moscatiello A; Nannini P; Petruzzi M; Picicco D; Picciotti M; Pisanelli S; Porta N; Ramponi G; Redaelli F; Rubini R; Sala N; Saitta V; Scelza G; Tiso RM; Tomasetto M; Torcoletti M; Travaini M; Valentini M; Vessia C
Vaccine; 2014 Jan; 32(5):527-34. PubMed ID: 24342249
[TBL] [Abstract][Full Text] [Related]
13. Emerging pneumococcal carriage serotypes in a high-risk population receiving universal 7-valent pneumococcal conjugate vaccine and 23-valent polysaccharide vaccine since 2001.
Leach AJ; Morris PS; McCallum GB; Wilson CA; Stubbs L; Beissbarth J; Jacups S; Hare K; Smith-Vaughan HC
BMC Infect Dis; 2009 Aug; 9():121. PubMed ID: 19650933
[TBL] [Abstract][Full Text] [Related]
14. Carriage prevalence and serotype distribution of Streptococcus pneumoniae prior to 10-valent pneumococcal vaccine introduction: A population-based cross-sectional study in South Western Uganda, 2014.
Nackers F; Cohuet S; le Polain de Waroux O; Langendorf C; Nyehangane D; Ndazima D; Nanjebe D; Karani A; Tumwesigye E; Mwanga-Amumpaire J; Scott JAG; Grais RF
Vaccine; 2017 Sep; 35(39):5271-5277. PubMed ID: 28784282
[TBL] [Abstract][Full Text] [Related]
15. Pneumococcal Carriage in Children under Five Years in Uganda-Will Present Pneumococcal Conjugate Vaccines Be Appropriate?
Lindstrand A; Kalyango J; Alfvén T; Darenberg J; Kadobera D; Bwanga F; Peterson S; Henriques-Normark B; Källander K
PLoS One; 2016; 11(11):e0166018. PubMed ID: 27829063
[TBL] [Abstract][Full Text] [Related]
16. Do combined upper airway cultures identify lower airway infections in children with chronic cough?
Hare KM; Chang AB; Smith-Vaughan HC; Bauert PA; Spain B; Beissbarth J; Grimwood K
Pediatr Pulmonol; 2019 Jun; 54(6):907-913. PubMed ID: 31006971
[TBL] [Abstract][Full Text] [Related]
17. Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014.
Nakano S; Fujisawa T; Ito Y; Chang B; Suga S; Noguchi T; Yamamoto M; Matsumura Y; Nagao M; Takakura S; Ohnishi M; Ihara T; Ichiyama S
Vaccine; 2016 Jan; 34(1):67-76. PubMed ID: 26602268
[TBL] [Abstract][Full Text] [Related]
18. Periodic cycles of pneumococcal serotypes carried by children before and after 7-valent pneumococcal conjugate vaccine.
Paulo AC; Sá-Leão R
PLoS One; 2017; 12(4):e0176723. PubMed ID: 28453533
[TBL] [Abstract][Full Text] [Related]
19. Does a 10-valent pneumococcal-Haemophilus influenzae protein D conjugate vaccine prevent respiratory exacerbations in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: protocol for a randomised controlled trial.
O'Grady KA; Grimwood K; Cripps A; Mulholland EK; Morris P; Torzillo PJ; Wood N; Smith-Vaughan H; Revell A; Wilson A; Van Asperen P; Richmond P; Thornton R; Rablin S; Chang AB
Trials; 2013 Sep; 14():282. PubMed ID: 24010917
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of Streptococcus pneumoniae nasopharyngeal carriage with high heptavalent pneumococcal conjugate vaccine coverage in Central Greece.
Grivea IN; Tsantouli AG; Michoula AN; Syrogiannopoulos GA
Vaccine; 2011 Nov; 29(48):8882-7. PubMed ID: 21963873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
